Current issue
Clinical pharmacology in people living with HIV
Register now or learn more
Start a new submission or continue a submission in progress
Go to submission siteReady to submit? Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window)Expert Review of Clinical Pharmacology [ISSN 1751-2433]; [e-ISSN 1751-2441] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of clinical safety, tolerability, efficacy and therapeutic applications.
The journal also covers toxicity issues, adverse reactions, pharmacoeconomics, and societal issues. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore, the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.
Please note that the journal does not publish preclinical or Phase I-II studies, unless there is a clear indication for translational medicine. Each article is structured to incorporate the author's own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Expert Review of Clinical Pharmacology aims to address the needs of clinical and pharmaceutical researchers, drug development specialists, physicians, and other specialists and players who are actively meeting such challenges in modern biomedical practice.
The Editors welcome novel research in the following key areas:
The journal welcomes:
Please note that the journal does not publish case reports or case series. Letters to the Editor should discuss articles previously published in the journal.
Comprehensive coverage in each review article is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.
Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Clinical Pharmacology, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services.
Read the Instructions for Authors for information on how to submit your article. For any pre-submission enquiries, please contact the Commissioning Editor.
Explore the most recently published articles
Clinical pharmacology in people living with HIV
A forum for the commentary and analysis of current and emerging research approaches in the ADME-Tox arena, as well as metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions and drug classes. This journal offers accelerated publication.
A MEDLINE-indexed journal providing expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. It offers accelerated publication.
Publishes double-blinded articles on cost-benefit and pharmacoeconomic issues in clinical drug use, therapeutic approaches, and evidence-based medicine.
Personalized medicine in drug development and clinical practice
Covering the development and application of medicine in a personalized therapy setting. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it is necessary to treat patient populations using a tailored approach. It offers accelerated publication.
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Expert Review of Clinical Pharmacology.